약물 방출 풍선(DEB) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)
Drug Eluting Balloon Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
상품코드:1402922
리서치사:Transparency Market Research
발행일:2023년 11월
페이지 정보:영문 212 Pages
라이선스 & 가격 (부가세 별도)
한글목차
약물 방출 풍선(DEB) 시장 - 보고서의 범위
TMR의 세계 약물 방출 풍선(DEB) 시장에 대한 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 세계 약물 방출 풍선(DEB) 매출 정보를 제공합니다. 2023년을 기준 연도, 2031년을 예측 연도로 간주하여 2017-2031년 기간 시장을 분석합니다. 이 보고서는 또한 2023년부터 2031년까지 세계 약물 방출 풍선(DEB) 시장의 복합 연간 성장률(CAGR%)을 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. KOL(Key Opinion Leader), 업계 리더 및 제조업체를 인터뷰하는 1차 조사 활동의 대부분을 분석가들이 수행했으며, 2차 조사에는 약물 방출 풍선(DEB) 시장을 이해하기 위해 주요 업체의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서 참조가 포함되었습니다.
시장 현황
2023년 시장 가치
5억 7,110만 달러
2031년 시장 가치
10억 달러
CAGR
7.1%
이 보고서는 세계 약물 방출 풍선(DEB) 시장 경쟁 구도를 자세히 분석합니다. 세계 약물 방출 풍선(DEB) 시장에서 활동하는 주요 기업이 확인되며, 이들 각각은 다양한 속성 측면에서 프로파일링됩니다. 기업 프로파일, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 약물 방출 풍선(DEB) 시장 기업의 속성입니다.
목차
제1장 주요 요약
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
시장 세분화
개요
시장 역학
세계 시장 분석과 예측, 2023-2031년
제5장 주요 인사이트
파이프라인 분석
COVID-19 팬데믹이 업계에 미치는 영향
제6장 시장 분석과 예측 : 제품별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 제품별, 2023-2031
관상 동맥
말초
기타
시장 매력도 : 제품별
제7장 시장 분석과 예측 : 기술별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 기술별, 2023-2031
Paccocath
FreePac
TransPax
EnduraCoat
기타
시장 매력도 : 기술별
제8장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 최종사용자별, 2023-2031
병원 및 외래수술센터(ASC)
카테터 실험실
기타
시장 매력도 : 최종사용자별
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2023-2031
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력도 : 지역별
제10장 북미 시장 분석과 예측
제11장 유럽 시장 분석과 예측
제12장 아시아태평양 시장 분석과 예측
제13장 라틴아메리카 시장 분석과 예측
제14장 중동 및 아프리카 시장 분석과 예측
제15장 경쟁 구도
시장 기업--경쟁 매트릭스(기업 Tier 및 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
Bayer AG
Medtronic
B. Braun Melsungen AG
Cook Medical, Inc.
Boston Scientific Corporation
Becton, Dickson and Company
EuroCor
Terumo Corporation
Koninklijke Philips NV
LSH
영문 목차
영문목차
Drug Eluting Balloon Market - Scope of Report
TMR's report on the global drug eluting balloon market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global drug eluting balloon market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug eluting balloon market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug eluting balloon market.
Market Snapshot
Market Value in 2023
US$ 571.1 Mn
Market Value in 2031
US$ 1 Bn
CAGR
7.1%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug eluting balloon market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug eluting balloon market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug eluting balloon market.
The report delves into the competitive landscape of the global drug eluting balloon market. Key players operating in the global drug eluting balloon market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug eluting balloon market profiled in this report.
Key Questions Answered in Global drug eluting balloon Market Report:
What is the sales/revenue generated by drug eluting balloon across all regions during the forecast period?
What are the opportunities in the global drug eluting balloon market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Drug Eluting Balloon Market - Research Objectives and Research Approach
The comprehensive report on the global drug eluting balloon market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global drug eluting balloon market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug eluting balloon market.
Table of Contents
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug Eluting Balloon Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6. Drug Eluting Balloon Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2023-2031
6.3.1. Coronary Drug Eluting Balloon
6.3.2. Peripheral Drug Eluting Balloon
6.3.3. Others
6.4. Market Attractiveness, by Product
7. Drug Eluting Balloon Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2023-2031
7.3.1. Paccocath
7.3.2. FreePac
7.3.3. TransPax
7.3.4. EnduraCoat
7.3.5. Others
7.4. Market Attractiveness, by Technology
8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2023-2031
8.3.1. Hospitals and Ambulatory Surgery Centers
8.3.2. Cath Labs
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2023-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Drug Eluting Balloon Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2023-2031
10.2.1. Coronary Drug Eluting Balloon
10.2.2. Peripheral Drug Eluting Balloon
10.2.3. Others
10.3. Market Attractiveness, by Product
10.4. Market Value Forecast, by Technology, 2023-2031
10.4.1. Paccocath
10.4.2. FreePac
10.4.3. TransPax
10.4.4. EnduraCoat
10.4.5. Others
10.5. Market Attractiveness, by Technology
10.6. Market Value Forecast, by End-user, 2023-2031
10.6.1. Hospitals and Ambulatory Surgery Centers
10.6.2. Cath Labs
10.6.3. Others
10.7. Market Attractiveness, by End-user
10.8. Market Value Forecast, by Country, 2023-2031
10.8.1. U.S.
10.8.2. Canada
10.9. Market Attractiveness Analysis
10.9.1. By Product
10.9.2. By Technology
10.9.3. By End-user
10.9.4. By Country
11. Europe Drug Eluting Balloon Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2023-2031
11.2.1. Coronary Drug Eluting Balloon
11.2.2. Peripheral Drug Eluting Balloon
11.2.3. Others
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Technology, 2023-2031
11.4.1. Paccocath
11.4.2. FreePac
11.4.3. TransPax
11.4.4. EnduraCoat
11.4.5. Others
11.5. Market Attractiveness, by Technology
11.6. Market Value Forecast, by End-user, 2023-2031
11.6.1. Hospitals and Ambulatory Surgery Centers
11.6.2. Cath Labs
11.6.3. Others
11.7. Market Attractiveness, by End-user
11.8. Market Value Forecast, by Country/Sub-region, 2023-2031
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
11.9.1. By Product
11.9.2. By Technology
11.9.3. By End-user
11.9.4. By Country/Sub-region
12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2023-2031
12.2.1. Coronary Drug Eluting Balloon
12.2.2. Peripheral Drug Eluting Balloon
12.2.3. Others
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Technology, 2023-2031
12.4.1. Paccocath
12.4.2. FreePac
12.4.3. TransPax
12.4.4. EnduraCoat
12.4.5. Others
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, by End-user, 2023-2031
12.6.1. Hospitals and Ambulatory Surgery Centers
12.6.2. Cath Labs
12.6.3. Others
12.7. Market Attractiveness, by End-user
12.8. Market Value Forecast, by Country/Sub-region, 2023-2031
12.8.1. China
12.8.2. Japan
12.8.3. India
12.8.4. Australia & New Zealand
12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
12.9.1. By Product
12.9.2. By Technology
12.9.3. By End-user
12.9.4. By Country/Sub-region
13. Latin America Drug Eluting Balloon Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2023-2031
13.2.1. Coronary Drug Eluting Balloon
13.2.2. Peripheral Drug Eluting Balloon
13.2.3. Others
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Technology, 2023-2031
13.4.1. Paccocath
13.4.2. FreePac
13.4.3. TransPax
13.4.4. EnduraCoat
13.4.5. Others
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, by End-user, 2023-2031
13.6.1. Hospitals and Ambulatory Surgery Centers
13.6.2. Cath Labs
13.6.3. Others
13.7. Market Attractiveness, by End-user
13.8. Market Value Forecast, by Country/Sub-region, 2023-2031
13.8.1. Brazil
13.8.2. Mexico
13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
13.9.1. By Product
13.9.2. By Technology
13.9.3. By End-user
13.9.4. By Country/Sub-region
14. Middle East & Africa Drug Eluting Balloon Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2023-2031
14.2.1. Coronary Drug Eluting Balloon
14.2.2. Peripheral Drug Eluting Balloon
14.2.3. Others
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Technology, 2023-2031
14.4.1. Paccocath
14.4.2. FreePac
14.4.3. TransPax
14.4.4. EnduraCoat
14.4.5. Others
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, by End-user, 2023-2031
14.6.1. Hospitals and Ambulatory Surgery Centers
14.6.2. Cath Labs
14.6.3. Others
14.7. Market Attractiveness, by End-user
14.8. Market Value Forecast, by Country/Sub-region, 2023-2031
14.8.1. GCC Countries
14.8.2. South Africa
14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
14.9.1. By Product
14.9.2. By Technology
14.9.3. By End-user
14.9.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Bayer AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Medtronic
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. B. Braun Melsungen AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Cook Medical, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Boston Scientific Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Becton, Dickson and Company
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. EuroCor
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Terumo Corporation
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Koninklijke Philips N.V.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
